Insiders · ENFN

Roy Luo

Director at Enfusion, Inc. (ENFN)

Roy Luo has filed 2 insider reports with the SEC since October 2021, as director at Enfusion, Inc. (ENFN). Roy Luo made no open-market purchases or sales in the last 12 months. The latest filing, on April 23, 2025, reports sale back to the company at Enfusion, Inc. (ENFN).

Filings
2
Companies
1
Bought on market
$21.4M
Sold on market
None

Companies where Roy Luo is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Enfusion, Inc. logo
ENFN
Enfusion, Inc.
Director$21.4M$17.00Apr 23, 2025

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Roy Luo with

Other insiders at the same companies

Questions about Roy Luo

What is Roy Luo's role at Enfusion, Inc.?
Roy Luo reports to the SEC as director at Enfusion, Inc. (ENFN), according to the latest filing on April 23, 2025.
Has Roy Luo bought or sold stock recently?
The most recent open-market purchase was on October 25, 2021: bought 1,261,594 shares of Enfusion, Inc. (ENFN) for $21.4M at an average of $17.00.
How do I get alerts when Roy Luo files?
Follow Roy Luo on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Roy Luo (SEC CIK 0001886869). Totals count each trade once, skipping amendments whose original is on file, from Oct 27, 2021 on. View on SEC EDGAR · Get this as JSON